Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Leren

Showing results (101-110 of 302) with videos related to

Pageof 31
Sort By:
Acta Paediatrica (Oslo, Norway : 1992)|February 24, 2001
Does maternal or paternal heredity affect carotid atherosclerosis in children with familial hypercholesterolaemia?S Tonstad, O Joakimsen, T P Leren, et al.
Stroke|October 1, 1993
Risk factors of stroke incidence and mortality. A 12-year follow-up of the Oslo StudyL L Håheim, I Holme, I Hjermann, et al.
Biochemical Pharmacology|March 15, 1978
Binding of quinidine in sera with different levels of triglycerides, cholesterol, and orosomucoid proteinO G Nilsen, P Leren, I Aakesson, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|June 1, 1983
Influence of body weight on plasma catecholamine patterns in middle-aged, normotensive menS E Kjeldsen, I Eide, I Aakesson, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|June 1, 1983
Increased arterial catecholamine concentrations in 50-year-old men with essential hypertensionS E Kjeldsen, I Eide, I Aakesson, et al.
Lancet (London, England)|December 12, 1981
Effect of diet and smoking intervention on the incidence of coronary heart disease. Report from the Oslo Study Group of a randomised trial in healthy menI Hjermann, K Velve Byre, I Holme, et al.
Atherosclerosis|July 20, 2018
MK-2206, an allosteric inhibitor of AKT, stimulates LDLR expression and LDL uptake: A potential hypocholesterolemic agentKatrine Bjune, Hilde Sundvold, Trond P Leren, et al.
Journal of Hypertension|August 1, 1995
Risk of fatal stroke according to blood pressure level: an 18-year follow-up of the Oslo StudyL L Håheim, I Holme, I Hjermann, et al.
Molecular Genetics and Metabolism Reports|November 11, 2016
Variable phenotypic expression of nonsense mutation p.Thr5* in the APOE geneTrond P Leren, Thea Bismo Strøm, Knut Erik Berge
British Medical Journal|August 5, 1978
High-density lipoprotein cholesterol and antihypertensive drugs: the Oslo studyA Helgeland, I Hjermann, P Leren, et al.
Pageof 31

Showing results (101-110 of 302) with videos related to

Sort By:
Pageof 31
Acta Paediatrica (Oslo, Norway : 1992)|February 24, 2001
Does maternal or paternal heredity affect carotid atherosclerosis in children with familial hypercholesterolaemia?S Tonstad, O Joakimsen, T P Leren, et al.
Stroke|October 1, 1993
Risk factors of stroke incidence and mortality. A 12-year follow-up of the Oslo StudyL L Håheim, I Holme, I Hjermann, et al.
Biochemical Pharmacology|March 15, 1978
Binding of quinidine in sera with different levels of triglycerides, cholesterol, and orosomucoid proteinO G Nilsen, P Leren, I Aakesson, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|June 1, 1983
Influence of body weight on plasma catecholamine patterns in middle-aged, normotensive menS E Kjeldsen, I Eide, I Aakesson, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|June 1, 1983
Increased arterial catecholamine concentrations in 50-year-old men with essential hypertensionS E Kjeldsen, I Eide, I Aakesson, et al.
Lancet (London, England)|December 12, 1981
Effect of diet and smoking intervention on the incidence of coronary heart disease. Report from the Oslo Study Group of a randomised trial in healthy menI Hjermann, K Velve Byre, I Holme, et al.
Atherosclerosis|July 20, 2018
MK-2206, an allosteric inhibitor of AKT, stimulates LDLR expression and LDL uptake: A potential hypocholesterolemic agentKatrine Bjune, Hilde Sundvold, Trond P Leren, et al.
Journal of Hypertension|August 1, 1995
Risk of fatal stroke according to blood pressure level: an 18-year follow-up of the Oslo StudyL L Håheim, I Holme, I Hjermann, et al.
Molecular Genetics and Metabolism Reports|November 11, 2016
Variable phenotypic expression of nonsense mutation p.Thr5* in the APOE geneTrond P Leren, Thea Bismo Strøm, Knut Erik Berge
British Medical Journal|August 5, 1978
High-density lipoprotein cholesterol and antihypertensive drugs: the Oslo studyA Helgeland, I Hjermann, P Leren, et al.
Pageof 31